Sara Eyal Selected Research

Sara Eyal Research Topics

Disease

12	Epilepsy (Aura) 02/2024 - 02/2014
8	Neoplasms (Cancer) 12/2021 - 05/2005
4	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2012
3	Inflammation (Inflammations) 02/2024 - 01/2016
3	Triple Negative Breast Neoplasms 01/2023 - 12/2018
3	Seizures (Absence Seizure) 11/2020 - 02/2014
2	Status Epilepticus (Complex Partial Status Epilepticus) 02/2024 - 01/2018
2	Drug-Related Side Effects and Adverse Reactions 01/2022 - 02/2014
2	Temporal Lobe Epilepsy 01/2019 - 01/2018
2	Cerebral Malaria 01/2017 - 01/2016
1	Neurodevelopmental Disorders 01/2023
1	COVID-19 12/2022
1	Adenocarcinoma 12/2021
1	Stroke (Strokes) 12/2018
1	Malaria 11/2018
1	Chronic Disease (Chronic Diseases) 10/2017
1	Medulloblastoma 10/2017
1	Rectal Neoplasms (Rectal Cancer) 04/2017
1	Infections 01/2017
1	Hypersensitivity (Allergy) 10/2016
1	Neoplasm Metastasis (Metastasis) 07/2015
1	Alzheimer Disease (Alzheimer's Disease) 07/2014
1	Hypertension (High Blood Pressure) 09/2010

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2012
5	Anticonvulsants (Antiepileptic Drugs)IBA 12/2018 - 05/2005
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2021 - 01/2016
3	Pilocarpine (Ocusert)FDA LinkGeneric 02/2024 - 01/2016
3	Valproic Acid (Depakote)FDA LinkGeneric 01/2023 - 05/2005
3	Liposomes (Liposome)IBA 12/2021 - 01/2016
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2021 - 07/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2022
2	nirmatrelvir and ritonavir drug combinationIBA 12/2022 - 01/2022
2	EnzymesIBA 01/2022 - 12/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2021 - 04/2014
2	Quinine (Quinson)FDA Link 12/2021 - 11/2018
2	Ferrosoferric Oxide (Magnetite)FDA Link 01/2019 - 01/2016
2	LithiumIBA 01/2019 - 01/2016
2	Reduced Folate Carrier ProteinIBA 01/2018 - 07/2015
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018 - 07/2015
1	CathepsinsIBA 02/2024
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	HexosesIBA 01/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	Cytochrome P-450 CYP3AIBA 01/2022
1	Diazepam (Valium)FDA LinkGeneric 01/2022
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	Everolimus FDA Link 01/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2021
1	liposomal doxorubicin (Doxil)FDA Link 12/2021
1	CannabidiolIBA 01/2021
1	Equilibrative Nucleoside Transporter 1IBA 01/2021
1	Lacosamide FDA Link 12/2018
1	Quinidine (Chinidin)FDA LinkGeneric 11/2018
1	Proton-Coupled Folate TransporterIBA 01/2018
1	1-dodecylpyridoxal (PLD)IBA 10/2017
1	PolymersIBA 01/2017
1	artemisoneIBA 01/2017
1	Coloring Agents (Dyes)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 07/2015
1	Peptides (Polypeptides)IBA 07/2015
1	AnionsIBA 07/2015
1	Thyroid HormonesIBA 07/2015
1	Membrane Transport Proteins (Biological Pump)IBA 07/2015
1	ATP-Binding Cassette Sub-Family B Member 4IBA 07/2015
1	Hormones (Hormone)IBA 07/2015
1	Amyloid (Amyloid Fibrils)IBA 07/2014
1	Nonprescription Drugs (Patent Medicines)IBA 02/2014
1	ErbB Receptors (EGF Receptor)IBA 01/2014
1	Clonidine (ST 155)FDA LinkGeneric 09/2010
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 09/2010
1	CationsIBA 11/2009
1	tetraphenylphosphonium (tetraphenylphosphonium chloride)IBA 11/2009
1	AcidsIBA 05/2005
1	2,2,3,3- tetramethylcyclopropanecarboxylic acidIBA 05/2005
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2005
1	valnoctic acidIBA 05/2005
1	CarbonIBA 05/2005
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 05/2005

Therapy/Procedure

5	Therapeutics 01/2023 - 02/2014
1	Precision Medicine 02/2024
1	Drug Substitution 10/2022
1	Photochemotherapy (Photodynamic Therapy) 12/2021
1	Immunomodulation 11/2020
1	Intravenous Administration 04/2017
1	Drug Therapy (Chemotherapy) 07/2015